IMB Dx

[On Demand]
Search General Info
Search Education
Search Partnering Companies
IMB Dx is a precision oncology company that develops minimally-invasive liquid biopsy tests for safe & affordable cancer diagnosis and monitoring. Our proprietary technology detects and analyzes trace amount of circulating tumor DNA (ctDNA) with only a single draw of blood. We are committed to providing useful information for patients and physicians, and to revolutionize the way cancer is diagnosed, monitored, and treated.

Our flagship panel, AlphaLiquid®100, is a multi-cancer monitoring panel for advanced-stage cancer patients. It offers information on cancer progress of the patient, FDA-approved therapies for each detected mutation, and on-going clinical trials.
Speaker
photo
CEO
IMB Dx